NCT04169763View on ClinicalTrials.gov

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 7, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Stage II Vulvar Cancer AJCC v8Stage III Vulvar Cancer AJCC v8Stage IIIA Vulvar Cancer AJCC v8Stage IIIB Vulvar Cancer AJCC v8Stage IIIC Vulvar Cancer AJCC v8Stage IVA Vulvar Cancer AJCC v8

Interventions

DRUG

Cisplatin

Given IV

RADIATION

External Beam Radiation Therapy

Undergo EBRT

DRUG

Nelfinavir

Given PO

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER